Daejeon, South Korea

Kyun Do Kim

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyun Do Kim. Retrieved from https://idiyas.com/inventor/kyun-do-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 11.2

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kyun Do Kim: Innovator in Intracellular Delivery Systems

Introduction

Kyun Do Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for intracellular delivery systems.

Latest Patents

Kyun Do Kim holds a patent for a transmembrane domain derived from the human LRRC24 protein. This invention relates to a transmembrane domain known as the LRRC24P transmembrane domain, which can be utilized as a cell-penetrating peptide. The technology enables the effective delivery of cargo materials, including compounds, biomolecules, and various polymer materials into cells. The LRRC24P transmembrane domain demonstrates higher cell penetration efficiency compared to conventional cell-penetrating peptides. Additionally, since it is derived from human proteins, it minimizes the risk of side effects and immune responses associated with foreign protein-derived peptides.

Career Highlights

Kyun Do Kim is affiliated with the Korea Research Institute of Chemical Technology, where he continues to advance research in chemical technology and biotechnology. His work focuses on enhancing the efficiency of drug delivery systems, which has significant implications for medical applications.

Collaborations

Kyun Do Kim collaborates with notable colleagues, including Seong Jun Kim and In Su Hwang, to further his research and development efforts in the field.

Conclusion

Kyun Do Kim's innovative work in developing the LRRC24P transmembrane domain represents a significant advancement in intracellular delivery systems. His contributions are poised to enhance the effectiveness of therapeutic applications in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…